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Primary upper gastrointestinal tract melanoma is a rare but well recognised entity, with a poor prognosis because
of delay in diagnosis. Furthermore, it may be difficult to determine whether a gastrointestinal melanoma represents
a metastasis or a primary tumour. We report a 67-year-old man with a primary oesophageal melanoma, treated with
surgical resection, who remains disease-free two years post resection.Background
Most melanomas involving the gastrointestinal tract rep-
resent metastasis from known or unknown cutaneous or
extracutaneous primary tumours. Primary upper gastro-
intestinal tract melanoma is rare and carries a poor
prognosis [1]. The first suspected, but not histologically
confirmed, case of primary oesophageal melanoma was re-
ported in 1906 by Bauer [2]. Garfinkle reported histo-
logical evidence of a melanocytic naevus (as a presumed
precursor lesion) adjacent to a primary gastroesophageal
melanoma in 1956 [3], following Allen and Spitz’s sugges-
tion of histological features required for such diagnosis
[4]. Numerous case reports have been published since, but
in many reports the documented clinical and pathological
evidence indicating primary oesophageal melanoma was
very limited, raising doubts about the true nature of some
of these cases. The c-KIT mutation status for example,
was reported in only four cases of primary oesophageal
melanoma out of 337 cases reviewed in a recent report
[1]. In this report, we document the clinical, pathological
(including somatic mutation status), treatment and follow
up details of a primary oesophageal melanoma.
Case presentation
A 67-year-old Singaporean man of Fitzpatrick’s skin type
III [5], with Chinese ancestry, few naevi and only minimal
previous sun exposure, presented to his family physician
with a two-year history of persistent and progressively
worsening left-sided chest pain, which began following a* Correspondence: eric.song@health.nsw.gov.au
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drugs or muscle relaxants, and investigations for cardio-
vascular causes of his pain were negative. In July 2009, a
gastroscopy was performed which revealed a plaque
with patchy, brownish discoloration arising from the
distal oesophagus and extending into the gastric cardia
as a polypoid mass (Figure 1).
A tissue biopsy showed a poorly differentiated malignant
tumour with morphological and immunohistochemical
features consistent with melanoma (S-100 protein, Melan
A/MART-1 and HMB45/Gp100 all positive). Full body
positron emission tomography coupled with a non-contrast
computerized tomography scan (PET-CT) showed exten-
sive thickening of the oesophageal and gastric walls, with
several enlarged perigastric lymph nodes strongly suggest-
ive of malignancy (Figure 2). Thorough skin and eye exami-
nations did not reveal any melanoma or suspicious lesion.
Total gastrectomy and partial oesophagectomy with
lymph node clearance was performed. Conventional
Roux-en-Y oesophagojejunostomy with distal jejunojeju-
nostomy was used for reconstruction. Pathology showed
a melanoma with a maximal thickness of 4 cm involving
the distal oesophagus, extending into the gastric submucosa
(Figure 3). It had a maximal diameter of 11 cm and ex-
tended through the muscularis propria to the serosa. The
tumour was composed of confluent sheets of pleomorphic,
rounded or spindle cells with enlarged nuclei, prominent
nucleoli, and frequent mitoses (15/mm2) (Figure 3). Melan-
oma was focally present in the oesophageal squamous mu-
cosa overlying the invasive tumour consistent with primary
rather than secondary disease (Figure 3). Resection margins
were clear.
Seven of ten nodes from the lesser curvature of the stom-
ach were positive for melanoma, staining positively for
Melan A, S-100 and HMB45 on immunohistochemistry,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Gastroscopic findings. (A) Gastroscopy revealed an
irregularly thickened, pigmented lesion at the distal end of the
oesophagus. A polypoid tumour mass protruding through the
gastroesophageal junction was seen (B) when viewed from
the stomach.
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revealed no somatic mutations in BRAF exon 15 or c-KIT
exons 11, 13 or 17. On the basis of the absence of prior or
concurrent melanoma elsewhere, the presence of melan-
oma in the squamous epithelium and the pattern of spread
of the tumour to local lymph nodes, a diagnosis of pri-
mary melanoma of the oesophagus, with regional nodal
metastasis (AJCC stage IIIc) was rendered. The patient
was followed up with PET-CT post resection. There has
been no clinical or radiological evidence of recurrent
local or distant disease, and he remains well two years
postoperatively.
Discussion
A diagnosis of primary extracutaneous melanoma should
not be rendered without first considering whether the
tumour may represent a metastasis from an unrecognized
or misdiagnosed melanoma [1]. Therefore a thorough his-
tory and examination is required to exclude a previous orFigure 2 Positron emission tomography coupled with
computerized tomography showed cardia and gastric wall
thickening and a lymph node with strongly positive isotope
uptake along the lesser curvature.synchronous cutaneous or extracutaneous primary melan-
oma elsewhere, including a regressed lesion or a previ-
ously removed melanocytic lesion misdiagnosed as a
naevus. The presence of melanoma involving the mucosa
overlying and adjacent to an invasive mucosal melanoma
is also evidentiary support of a primary mucosal origin be-
cause it suggests in situ disease. However, this is not de-
finitive because metastatic melanoma can show epithelial
tropism and mimic a primary tumour histologically. Be-
cause it usually presents clinically at a locally advanced
stage, the surface mucosa is usually ulcerated in primary
oesophageal melanoma and hence an in situ melanoma
component may not be identifiable. Finally, a credible
diagnosis of primary oesophageal melanoma also requires
that the pattern of any spread of the disease is consistent
with the primary site of the tumour.
The occurrence of primary melanomas in mucosal
sites has long been recognised. Melanocytes have been
identified in normal individuals in most of these mucosal
sites, including the oesophagus [6], providing a plausible
histogenetic basis for the origin of these melanomas.
Risk factors specific for primary gastrointestinal mel-
anoma are not clear. A recent review suggested that risk
factors for cutaneous melanoma such as skin type,
family history or sun exposure did not appear to be im-
portant for extracutaneous melanoma [1]. The clinical
features of those patients reported in the literature to
have oesophageal melanoma were similar to those of pa-
tients with oesophageal malignancies in general: most
patients were men in their 60s or 70s [1]. Interestingly,
primary oesophageal melanoma, like primary oesophageal
carcinoma, occurs more frequently in Asian individuals
compared to Caucasians [1,7]. However, other risk factors
for oesophageal cancer such as gastroesophageal reflux
disease, Barrett’s oesophagus, smoking, obesity and diet
have not been implicated as risk factors for primary
oesophageal melanoma. The estimated disease frequency
was 0.1 to 0.2% of all oesophageal malignancies [1], with
reported two- and five-year survival rates of 24 and 4.5%,
respectively [1].
Activating mutations or gene amplification of the tyro-
sine kinase receptor c-KIT are present in 10 to 15% of
acral and mucosal melanomas [8]. Langer et al. exam-
ined ten cases of primary oesophageal melanomas and
found two cases with c-KIT mutations [9]. No c-KIT
mutation was identified in our patient. Because muta-
tions in c-KIT (and BRAF) are now being successfully
exploited by new targeted therapies, it would appear ap-
propriate to perform relevant mutation testing of pri-
mary extracutaneous melanoma in patients in whom
systemic treatment is being considered.
The treatment of choice for primary oesophageal mel-
anoma is radical surgical excision. Prognosis is generally
very poor, with the principal determinant of outcome
Figure 3 Histopathologic findings. Histopathology showed an exophytic and endophytic tumour involving the distal oesophagus (A),
comprised of large, pleomorphic tumour cells with frequent mitoses (15/mm2) (B). Melanoma also involved the oesophageal squamous mucosa
consistent with in situ disease (C).
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metastases.Conclusion
Primary melanomas of the gastrointestinal tract are rare.
Diagnosis requires exclusion of a metastasis through
careful evaluation of the clinical history, physical examin-
ation, and pathological evaluation. Although the prognosis
is poor, surgery for selected patients with resectable dis-
ease offers the best chance of cure. Recently developed
targeted therapies may improve the therapeutic options
for patients requiring systemic therapies for advanced
stage disease.Consent
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